Japan based Eisai Co., Ltd. has announced that it has launched the in-house discovered and developed antiepileptic drug ...
CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Co...
China based Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high qual...
AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...
China headquartered Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufact...
Antengene Corporation has announced its appointment of Mr. John Chin, MBA, as Chief Business Officer (CBO). He will be r...
I-Mab Biopharma ("I-Mab"), a global biopharmaceutical company based in China and the United States a...
US based Leap Therapeutics, Inc. a biotechnology company developing targeted immuno-oncology therapeutics, and China hea...
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec has announced the opening of its...
BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-t...
China based Fountain Medical Development Limited ("Fountain Medical" or "Company"), a clinical stage CRO dedicated to of...
China based CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory dru...
Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for In...
AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintena...
Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading...
The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility&...
Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that the China National Medica...
China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Adminis...
